Adlai Nortye Ltd. (NASDAQ:ANL - Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $8.29, but opened at $11.07. Adlai Nortye shares last traded at $14.00, with a volume of 138,436 shares.
Analyst Upgrades and Downgrades
Separately, Cantor Fitzgerald restated an "overweight" rating on shares of Adlai Nortye in a research note on Friday, January 12th.
Read Our Latest Research Report on ANL
Adlai Nortye Stock Performance
The firm's fifty day moving average is $8.35.
Institutional Trading of Adlai Nortye
An institutional investor recently raised its position in Adlai Nortye stock. Cantor Fitzgerald L. P. lifted its position in shares of Adlai Nortye Ltd. (NASDAQ:ANL - Free Report) by 128.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,310 shares of the company's stock after purchasing an additional 22,644 shares during the quarter. Cantor Fitzgerald L. P. owned 0.11% of Adlai Nortye worth $362,000 at the end of the most recent reporting period. 35.21% of the stock is owned by institutional investors and hedge funds.
Adlai Nortye Company Profile
(
Get Free Report)
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas.
Further Reading
Before you consider Adlai Nortye, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adlai Nortye wasn't on the list.
While Adlai Nortye currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
